These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18246196)

  • 1. Making a bad thing worse: adverse effects of stress on drug addiction.
    Cleck JN; Blendy JA
    J Clin Invest; 2008 Feb; 118(2):454-61. PubMed ID: 18246196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction.
    Bowen MT; Neumann ID
    Trends Neurosci; 2017 Dec; 40(12):691-708. PubMed ID: 29128108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of addiction.
    Clay SW; Allen J; Parran T
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging the addicted human brain.
    Fowler JS; Volkow ND; Kassed CA; Chang L
    Sci Pract Perspect; 2007 Apr; 3(2):4-16. PubMed ID: 17514067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teaching the brain to take drugs.
    Wickelgren I
    Science; 1998 Jun; 280(5372):2045-6. PubMed ID: 9669958
    [No Abstract]   [Full Text] [Related]  

  • 6. New developments on the neurobiological and pharmaco-genetic mechanisms underlying internet and videogame addiction.
    Weinstein A; Lejoyeux M
    Am J Addict; 2015 Mar; 24(2):117-125. PubMed ID: 25864599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the place of neurobiological explanations in accounts of a family member's addiction.
    Meurk C; Fraser D; Weier M; Lucke J; Carter A; Hall W
    Drug Alcohol Rev; 2016 Jul; 35(4):461-9. PubMed ID: 26332006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging brain response to reward in addictive disorders.
    Hommer DW; Bjork JM; Gilman JM
    Ann N Y Acad Sci; 2011 Jan; 1216():50-61. PubMed ID: 21272010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Multidimensional Therapeutic Potential of Targeting the Brain Oxytocin System for the Treatment of Substance Use Disorders.
    Bowen MT; Neumann ID
    Curr Top Behav Neurosci; 2018; 35():269-287. PubMed ID: 28942596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of stress on the transition from drug use to addiction.
    Wand G
    Alcohol Res Health; 2008; 31(2):119-36. PubMed ID: 23584814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.
    Lee MR; Rohn MC; Tanda G; Leggio L
    CNS Drugs; 2016 Feb; 30(2):109-23. PubMed ID: 26932552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiological mechanisms of early life adversity, blunted stress reactivity and risk for addiction.
    al'Absi M; Ginty AT; Lovallo WR
    Neuropharmacology; 2021 May; 188():108519. PubMed ID: 33711348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting drug interactions in addiction treatment.
    Lucas CJ; Patel J; Martin JH
    Intern Med J; 2017 Aug; 47(8):872-878. PubMed ID: 28782217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existing and Future Drugs for the Treatment of the Dark Side of Addiction.
    Koob GF; Mason BJ
    Annu Rev Pharmacol Toxicol; 2016; 56():299-322. PubMed ID: 26514207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Therapy.
    He RH; Tao R
    Adv Exp Med Biol; 2017; 1010():219-245. PubMed ID: 29098675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma Receptors and Substance Use Disorders.
    Sabino V; Hicks C; Cottone P
    Adv Exp Med Biol; 2017; 964():177-199. PubMed ID: 28315272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug addiction: the neurobiology of behaviour gone awry.
    Volkow ND; Li TK
    Nat Rev Neurosci; 2004 Dec; 5(12):963-70. PubMed ID: 15550951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?
    McGregor IS; Callaghan PD; Hunt GE
    Br J Pharmacol; 2008 May; 154(2):358-68. PubMed ID: 18475254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarities and Differences in Neurobiology.
    Chen M; Sun Y; Lu L; Shi J
    Adv Exp Med Biol; 2017; 1010():45-58. PubMed ID: 29098667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?".
    James MH; Aston-Jones G
    Brain Res; 2020 Mar; 1731():146665. PubMed ID: 31930996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.